Schedule Dispatches

This is an early notification of the changes to be announced in the Update to the Pharmaceutical Schedule.

The full Update is available as a PDF(external link)

The changes will be published in the online Schedule around the 23^rd of this month and are effective from next month.

For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz

18 June 2025 | July 2025 Pharmaceutical Schedule Dispatch

New Listings

• Calcitonin (Miacalcic S29) inj 100 iu per ml, 1 ml ampoule – section 29 and wastage claimable (p’code 2709317)
• Efavirenz with emtricitabine and tenofovir disoproxil (TEEVIR) tab 600 mg with emtricitabine 200 mg and tenofovir disoproxil 245 mg (300 mg as a fumarate) – Special Authority-Retail pharmacy, section 29 and wastage claimable (p’code 2705508)
• Labetalol (Biocon) tab 100 mg – section 29 and wastage claimable (p’code 2708809)
• Lanreotide (Mytolac S29) inj 60 mg per 0.5 ml, 0.5 ml syringe – Special Authority-Retail pharmacy, section 29 and wastage claimable (p’code 2709597)
• Mesalazine (Asacol) tab 1,600 mg – section 29 and wastage claimable (p’code 2709325)
• Palbociclib (Palbociclib Pfizer) tab 75 mg (p’code 2709058), tab 100 mg (p’code 2709066) and tab 125 mg (p’code 2709074) – Special Authority-Retail pharmacy and wastage claimable
• Pegylated interferon alfa-2a (Pegasys S29) inj 180 mcg prefilled syringe – Special Authority-Retail pharmacy, section 29 and wastage claimable (p’code 2706768)
• Pregabalin (Lyrica) cap 25 mg (p’code 2704498), cap 75 mg (p’code 2704501), cap 150 mg (p’code 2704528) and cap 300 mg (p’code 2704536)
• Promethazine hydrochloride (Allersoothe) tab 10 mg (p’code 2700190) and tab 25 mg (p’code 2700204), 100 tab pack
• Sodium fusidate [Fusidic acid] (Fucithalmic S29) eye drops 1%, 5 g OP – section 29 (p’code 2709309)

Changes to restrictions, chemical names and presentations

• Dabrafenib (Tafinlar) cap 50 mg and 75 mg – amended Special Authority criteria
• Dulaglutide (Trulicity) inj 1.5 mg per 0.5 ml prefilled pen – amended Special Authority criteria
• Efavirenz (Efavirenz Milpharm) tab 600 mg – addition of note
• Ipratropium bromide (Atrovent) aerosol inhaler, 20 mcg per dose CFC-free – addition of no patient co-payment payable
• Insulin pump infusion set (Steel cannula, straight insertion) (mylife Orbit micro) 5.5 mm steel cannula; straight insertion; 45 cm line × 10 with 10 needles and 5.5 mm steel cannula; straight insertion; 60 cm line × 10 with 10 needles – addition of stat dispensing
• Oral feed 1.5 kcal/ml liquid (banana), 200 ml bottle (Ensure Plus and Fortisip), liquid (chocolate), 200 ml bottle (Ensure Plus and Fortisip), liquid (fruit of the forest), 200 ml bottle (Ensure Plus), liquid (strawberry), 200 ml bottle (Fortisip), liquid (vanilla), 200 ml bottle (Ensure Plus and Fortisip) and liquid (vanilla), 237 ml can (Ensure Plus) – amended endorsement criteria
• Pembrolizumab inj 25 mg per ml, 4 ml vial (Keytruda) and inj 1 mg for ECP (Baxter) – amended Special Authority criteria
• Ribociclib (Kisqali) tab 200 mg – amended Special Authority criteria
• Rituximab (Riximyo) inj 100 mg per 10 ml vial, inj 500 mg per 50 ml vial (Riximyo) and inj 1 mg for ECP (Baxter (Riximyo)) – amended Special Authority criteria
• Teriflunomide (Teriflunomide Sandoz) tab 14 mg – removal of brand switch fee payable
• Trametinib (Mekinist) tab 0.5 mg and 2 mg – amended Special Authority criteria
• Zoledronic acid (Zoledronic Acid Injection Mylan) inj 4 mg per 5 ml, vial – brand name change

Increased subsidy

Chemical	Presentation	Fully subsidised brands
Clozapine	Suspension 50 mg per ml, 100 ml	Versacloz
Hydrocortisone with natamycin and neomycin	Oint 1% with natamycin 1% and neomycin 0.5%, 15 g OP	Pimafucort
Oestradiol	Patch 25 mcg, 50 mcg, 75 mcg and 100 mcg per day	Estradot
Tetracycline	Tab 250 mg	Accord

Decreased subsidy

Chemical	Presentation	Fully subsidised brands
Adrenaline	Inj 0.15 mg per 0.3 ml auto-injector, 1 OP Inj 0.3 mg per 0.3 ml auto-injector, 1 OP	Epipen Jr Epipen
Budesonide	Cap modified-release 3 mg	Budesonide Te Arai
Cetomacrogol with glycerol	Crm 90% with glycerol 10%, 460 g OP and 920 g OP	Evara
Codeine phosphate	Tab 15 mg and 30 mg	Noumed
Compound electrolytes	Powder for oral soln	Electral
Domperidone	Tab 10 mg	Domperidone Viatris
Emtricitabine with tenofovir disoproxil	Tab 200 mg with tenofovir disoproxil 245 mg (300 mg as a maleate)	Tenofovir Disoproxil Emtricitabine Viatris
Fludrocortisone acetate	Tab 100 mcg	Florinef
Iloprost	Nebuliser soln 10 mcg per ml, 2 ml	Vebulis
Levomepromazine hydrochloride	Inj 25 mg per ml, 1 ml ampoule	Wockhardt
Mercaptopurine	Tab 50 mg	Puri-nethol
Montelukast	Tab 10 mg	Montelukast Viatris
Oestradiol	Patch 25 mcg, 50 mcg, 75 mcg and 100 mcg per day	Estradiol TDP Mylan
Ondansetron	Tab 4 mg and 8 mg	Periset
Posaconazole	Tab modified-release 100 mg Oral liq 40 mg per ml, 105 ml OP	Posaconazole Juno Devatis
Pramipexole hydrochloride	Tab 0.25 mg and 1 mg	Ramipex
Tenofovir disoproxil	Tab 245 mg (300 mg as a maleate) Tab 245 mg (300 mg as a fumarate)	Tenofovir Disoproxil Viatris Ricovir